Serrated adenoma prevalence in inflammatory bowel disease surveillance colonoscopy, and characteristics revealed by chromoendoscopy and virtual chromoendoscopy

Canadian Journal of Gastroenterology and Hepatology

Volumn 28, Issue 11, 2014, Pages 589-594

  Iacucci, Marietta ^a   Hassan, Cesare ^a   Gasia, Miriam Fort ^a   Urbanski, Stefan ^b   Gui, Xianyong ^b   Eksteen, Bertus ^a   Eustace, Gregory ^a   Kaplan, Gilaad G ^a   Panaccione, Remo ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

High definition iScan virtual and dye chromoendoscopy; Inflammatory bowel disease; Sessile serrated adenoma

Indexed keywords

METHYLENE BLUE; COLORING AGENT;

ADULT; AGED; ARTICLE; ASCENDING COLON; CANCER DIAGNOSIS; CANCER SURGERY; CHROMOENDOSCOPY; CLINICAL FEATURE; COLON BIOPSY; COLON RESECTION; COLONOSCOPE; COLONOSCOPY; CONTRAST ENHANCEMENT; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; FEMALE; GASTROINTESTINAL DYSPLASIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY BOWEL DISEASE; ISCHEMIC COLITIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; RECTUM ADENOMA; RECTUM POLYP; SENSITIVITY AND SPECIFICITY; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; TUMOR VOLUME; ULCERATIVE COLITIS; ADENOMA; COLON POLYP; COLON TUMOR; COMPUTER INTERFACE; HEALTH SURVEY; MIDDLE AGED; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADENOMA; ADULT; AGED; AGED, 80 AND OVER; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; COLONIC POLYPS; COLONOSCOPY; COLORING AGENTS; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; USER-COMPUTER INTERFACE; YOUNG ADULT;

EID: 84919345051     PISSN: 22912789     EISSN: 22912797     Source Type: Journal    
DOI: 10.1155/2014/386540     Document Type: Article

References (44)

1. Eaden JA, KR Abrams, JF Mayberry. The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 2001;48:526-35.
2. Beaugerie L, Svrcek M, Seksik P, et al. Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology 2013;145:166-75.
3. Jess T, Simonsen J, Jørgensen KT, et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012;143:375-81
4. Lutgens MW, Van Oijen MG, Van Der Heijden GJ, et al. Declining risk of colorectal cancer in inflammatory bowel disease: An updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis 2013;19:789-99.
5. Francis A. Farraye, Robert D. Odze, Jayne Eaden, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010;138:738-45.
6. Rutter M, Bernstein C, Matsumoto T, et al. Endoscopic appearance of dysplasia in ulcerative colitis and the role of staining. Endoscopy 2004;36:1109-14.
7. Rutter MD, Saunders B P, Schofield G, et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004;53:256-60.
8. Kiesslich, R Fritsch J, Holtmann M, et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003;124:880-8.
9. Marion JF, Waye JD, Present DH, et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: A prospective endoscopic trial. Am J Gastroenterol 2008;103:2342-9.
10. Konijeti GG, Shrime MG, Ananthakrishnan AN, et al. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc 2013; S0016-5107.
11. Mowat C, Cole A, Windsor A, et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571-607.
12. Subramanian V, Mannath J, Ragunath K, et al. Meta-analysis: The diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011;33:304-12.
13. Subramanian V, Ramappa V, Telakis E, et al. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease. Inflamm Bowel Dis 2013;19:350-5.
14. Kodashima S, Fujishiro M. Novel image-enhanced endoscopy with i-Scan technology. World J Gastroenterol 2010;16:1043-9.
15. Hoffman A, Kagel C, Goetz M, et al. Recognition and characterization of small colonic neoplasia with high-definition colonoscopy using i-Scan is as precise as chromoendoscopy. Dig Liver Dis 2010;42:45-50.
16. Hong S. N, Choe WH, Lee JH, et al. Prospective, randomized, back-to-back trial evaluating the usefulness of i-Scan in screening colonoscopy. Gastrointest Endosc 2012;75:1011-21.
17. Ignjatovic A, East JE, Subramanian V, et al. Narrow band imaging for detection of dysplasia in colitis: A randomized controlled trial. Am J Gastroenterol 2012;10:885-90.
18. Efthymiou M, Allen PB, Taylor AC, et al. Chromoendoscopy versus narrow band imaging for colonic surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2132-8.
19. Rubio CA, Befrits R, Jaramillo E, et al. Villous and serrated adenomatous growth bordering carcinomas in inflammatory bowel disease. Anticancer Res 2000;20:4761-4.
20. Bossard C, Denis MG, Bezieau S, et al. Involvement of the serrated neoplasia pathway in inflammatory bowel disease-related colorectal oncogenesis Oncol Rep 2007;18:1093-7.
21. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end-points. Am J Surg Pathol 2006;30:1491-501.
22. Chaubert P, Benhattar J, Saraga E, et al. K-ras mutations and p53 alterations in neoplastic and non-neoplastic lesions associated with longstanding ulcerative colitis. Am J Pathol 1994;144:767-75.
23. Ishigooka S, Nomoto M, Obinata N, et al. Evaluation of magnifying colonoscopy in the diagnosis of serrated polyps. World J Gastroenterol 2012;18:4308-16.
24. Kimura T, Yamamoto E, Yamano HO, et al. A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma. Am J Gastroenterol 2012;107:460-9.
25. Kahi CJ, Li X, Eckert GJ, Rex DK. High colonoscopic prevalence of proximal colon serrated polyps in average-risk men and women. Gastrointest Endosc 2012;75:515-20.
26. Hazewinkel Y, López-Cerón M, East JE, et al. Endoscopic features of sessile serrated adenomas: Validation by international experts using high-resolution white-light endoscopy and narrow-band imaging Gastrointest Endosc 2013;7:916-24.
27. Iacucci M, Xianyong G, Love J, et al. Novel irregular vascular pattern features of serrated adenoma detected by high-definition iScan endoscopic technique. Gastrointest Endosc 2014;79:182-4.
28. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for midly to moderately active ulcerative colitis: A randomized study. N Engl J Med 1987;317:1625-9.
29. D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007;132:763-86.
30. Montreal World Congress of Gastroenterology. Montreal classification. Can J Gastroenterol 2005;19:5-36.
31. Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn's disease: The SES-CD. Gastrointest Endosc 2004;60:505-12.
32. Participants in the Paris Workshop. The Paris endoscopic classification of superficial neoplastic lesions: Esophagus, stomach, and colon. Gastrointest Endosc 2003;58:S3-43.
33. Kudo S, Tamura S, Nakajima T, et al. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc 1996;44:8-14.
34. Itzkowitz SH, Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004;126:1634-48.
35. Riddell RH, Goldman H, Ransohoff D F, et al. Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-68.
36. Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000;47:251-5.
37. Payne SR, Church TR, Wandell M, et al. Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps very on the basis of center. Clin Gastroenterol Hepatol 2014:12:1119-26.
38. Johnson DH, Khanna S, Smyrk TC, et al. Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis. Aliment Pharmacol Ther 2014;39:1408-17.
39. Dekker E, Van Den Broek FJ, Reitsma JB, et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007;39:216-21.
40. Van Den Broek FJ, Fockens P, Van Eeden S, et al. Narrow-band imaging versus high-definition endoscopy for the diagnosis of neoplasia in ulcerative colitis. Endoscopy 2011;43:108-15.
41. Ignjatovic A, East JE, Subramanian V, et al. Narrow band imaging for detection of dysplasia in colitis: A randomized controlled trial. Am J Gastroenterol 2012;10:885-90.
42. Efthymiou M, Allen PB, Taylor AC, et al. Chromoendoscopy versus narrow band imaging for colonic surveillance in inflammatory bowel disease. Inflamm Bowel Dis 2013;19:2132-8.
43. Pellisé M, López-Cerón M, Rodríguez De Miguel C, et al. Narrow-band imaging as an alternative to chromoendoscopy for the detection of dysplasia in long-standing inflammatory bowel disease: A prospective, randomized, crossover study. Gastrointest Endosc 2011;74:840-84.
44. Pellisé M, Fernández-Esparrach G, Cárdenas A, et al. Clinical impact of wide-angle, high-resolution endoscopy in the diagnosis of colorectal neoplasia in a non-selected population: A prospective randomized controlled trial. Gastroenterology 2008;135:1062-8.